Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00006454-199901000-00007PMID 9951975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Prevention of Hepatitis B Virus Infection and Liver Cancer.

  2020cites this paper
• Hepatitis B Virus Infection and the Progress toward its Elimination

  2019cites this paper
• New Advances in Hepatitis B Vaccination for Adults

  2018cites this paper
• Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices

  2018cites this paper
• 213 – Hepatitis B and Hepatitis D Viruses

  2018cites this paper
• Metabolomics in Newborns.

  2016cites this paper
• Chronic Hepatitis B Viral Infection

  2015cites this paper
• Prevention of hepatitis B virus infection and liver cancer.

  2014cites this paper
• [What do we learn from outbreaks of vaccine-preventable diseases?].

  2013cites this paper
• Vitamin C for preventing and treating pneumonia.

  2013cites this paper
• Meningitis: is a major cause of disability amongst Papua New Guinea children?

  2012cites this paper
• The clinician's guide to the anti-vaccinationists' galaxy.

  2012cites this paper
• Neurological complications of vaccination with outer surface protein A (OspA)

  2011cites this paper
• Postexposure prophylaxis for deadly bloodborne viral infections.

  2010cites this paper
• Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience.

  2010cites this paper
• Immunoprophylaxis of Hepatitis A and Hepatitis B in Children

  2010cites this paper
• Cancer prevention by vaccination against hepatitis B.

  2009cites this paper
• Atypical bacterial pathogens in community-acquired pneumonia in children: a hospital-based study

  2009cites this paper
• Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics.

  2009cites this paper
• Chapitre 19 – Acquisitions récentes en matière de vaccinations et vaccins du futur

  2009cites this paper
• S17. Cancer prevention by vaccination against hepatitis B

  2008cites this paper
• A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

  2006cites this paper
• Invasive pneumococcal disease in children <5 years of age in rural Mozambique

  2006cites this paper
• Vaccine Safety Controversies and the Future of Vaccination Programs

  2005cites this paper
• Las recientes imputaciones a las vacunas: interpretación actual

  2004cites this paper
• Immunology of hepatitis B virus

  2004cites this paper
• Safety of immunisation and adverse events following vaccination against hepatitis B

  2003cites this paper
• Safety of immunization and adverse events following vaccination against hepatitis B.

  2003cites this paper
• Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization

  2003cites this paper
• Viral Hepatitis Prevention Board meeting Geneva, March 13-14, 2003

  2003cites this paper
• Recent differing expert opinions regarding the safety profile of hepatitis B vaccines: is there really a controversy?

  2003cites this paper
• [A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination?].

  2002cites this paper
• Vaccines, viruses, and voodoo.

  2002cites this paper
• Afebrile Convulsion in an Adult after Recombinant Hepatitis B Vaccination

  2002cites this paper
• The science of evaluation of adverse events associated with vaccination.

  2002cites this paper
• Hepatitis B vaccine and risk of multiple sclerosis

  2002cites this paper
• Global control of hepatitis B virus infection.

  2002cites this paper
• Prevention of hepatocellular carcinoma by hepatitis B immunization

  2002cites this paper
• How vaccine safety is monitored before and after licensure.

  2001cites this paper
• [Hepatitis B vaccination and neurologic manifestations in children].

  2001cites this paper
• The stubborn facts of vaccine safety.

  2001cites this paper
• Challenges to vaccine safety.

  2001cites this paper
• Vaccination contre l'hépatite B et manifestations neurologiques chez l'enfant.

  2001cites this paper
• Hepatitis B vaccine: Risks and benefits of universal neonatal vaccination

  2001cites this paper
• [Secondary effects of vaccinations].

  2001cites this paper
• Vaccine safety–vaccine benefits:science and the public's perception

  2001cites this paper
• Understanding those who do not understand: a brief review of the anti-vaccine movement.

  2001cites this paper
• Toward the global elimination of hepatitis B virus transmission.

  2001cites this paper
• Management of hepatitis B: 2000--summary of a workshop.

  2001cites this paper
• Vaccine safety.

  2001cites this paper
• Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.

  2001cites this paper
• The risk of vaccination--the importance of "negative" studies.

  2001cites this paper
• Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant.

  2001cites this paper
• Is there a causal link between hepatitis B vaccination and multiple sclerosis?

  2000cites this paper
• School-based hepatitis B vaccination programme and adolescent multiple sclerosis.

  2000cites this paper
• Hepatitis B vaccination and control of hepatitis B-related liver disease.

  2000cites this paper
• [Vaccination, information and manipulation].

  2000cites this paper
• Host-pathogen interactions in emerging and re-emerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B, and cholera.

  2000cites this paper
• Current update of pediatric hepatitis vaccine use.

  2000cites this paper
• Vaccination, information et manipulation

  2000cites this paper
• Safety of Routine Childhood Vaccinations

  2000cites this paper
• Vaccines for children in rich and poor countries.

  1999cites this paper
• Prospects for hepatitis B virus eradication and control of hepatocellular carcinoma.

  1999cites this paper
• Over a decade of experience with a yeast recombinant hepatitis B vaccine.

  1999cites this paper
• Multiple sclerosis: a secretive disease.

  1999cites this paper